UnknownNCT05605951
Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve
Studying Neuromyelitis Optica
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul
- Principal Investigator
- Susanna AsseyerCharite University, Berlin, Germany
- Intervention
- non-interventional study(other)
- Enrollment
- 200 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2025
Study locations (26)
- University of Colorado School of Medicine, Aurora, Colorado, United States
- Harvard Medical School, Boston, Massachusetts, United States
- Departments of Neurology and Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States
- Hospital Aleman, Buenos Aires, Argentina
- Department of Neurology, Concord Hospital, Faculty of Medicine and Health, Sydney, Australia
- University of Botswana, Gaborone, Botswana
- Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
- Del Rosario University, Bogotá, Colombia
- Department of Ophthalmology, Oftlamo-Sanitas Eye Institute, School of Medicine, Fundación Universitaria Sanitas, Bogotá, Colombia
- Pontificia Universidad Javeriana, Bogotá, Colombia
- Department of Neurology, Slagelse, Institute for Health Research, University of Southern Denmark, Odense, Denmark
- (MIRCEM) Lyon Civil Hospices, France, Lyon, France
- Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Germany, Department of Neurology, Berlin, Germany
- Institute for Clinical Neuroimmunology, LMU Clinic of Ludwig-Maximilians Universität in Munich, Munich, Germany
- Nitte University, Karnataka, Mangalore, India
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05605951 on ClinicalTrials.govOther trials for Neuromyelitis Optica
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT05909761Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During PregnancyAmgen
- RECRUITINGPHASE3NCT05199688A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)Hoffmann-La Roche
- RECRUITINGPHASE4NCT07420296Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum DisorderTianjin Medical University General Hospital
- RECRUITINGNCT06885957Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSDTongji Hospital
- RECRUITINGPHASE1NCT06620809The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum DisordersTongji Hospital
- RECRUITINGNANCT06865274Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNANCT06780709Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSDIcahn School of Medicine at Mount Sinai
- ACTIVE NOT RECRUITINGPHASE3NCT06724809Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSDAlexion Pharmaceuticals, Inc.